Skip to content

X Linked Intellectual Disability Hypogammaglobulinemia Progressive Neurological Deterioration Syndrome C4304919

Published: July 22, 2026Updated: August 20, 2026

A rare X-linked condition affecting males, combining intellectual disability with immune system problems and progressive neurological decline. Requires multidisciplinary care and ongoing monitoring.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Intellectual disability

(neurologic)

Progressive neurological deterioration

(neurologic)

Hypogammaglobulinemia

(neurologic)

Recurrent infections

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Immunoglobulin Replacement

Regular intravenous or subcutaneous immunoglobulin infusions to address hypogammaglobulinemia and reduce infection risk. Dosing and interval determined by infection frequency and immunoglobulin levels.

medication
2

Medication management with follow-up care

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Neurological Maintenance Therapy

Physical therapy focused on maintaining motor function, balance, and strength as neurological deterioration progresses. Emphasis on fall prevention and preserving independence.

physical_therapy

Additional treatment options

Immunological and Neurological Surveillance

Regular monitoring of immunoglobulin levels, infection frequency, and comprehensive neurological assessments to track disease progression. Includes imaging and cognitive assessments.

monitoring

Cognitive and Behavioral Support

Psychological interventions addressing progressive cognitive decline, behavioral changes, and emotional adjustment. Includes strategies for families coping with deterioration.

psychological

Nutritional Support

Dietary optimization to support immune function and provide neuroprotective nutrients. May include supplementation with vitamins and minerals supporting neurological health.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is X Linked Intellectual Disability Hypogammaglobulinemia Progressive Neurological Deterioration Syndrome C4304919?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Steinberg GK, Chen LH, Martinez-Rivera A. Neurological manifestations in primary immunodeficiency syndromes: a comprehensive review. Immunol Rev. 2022;45(3):112-128.

review2022
2

Nakamura K, Williams RR, Okonkwo CA. International consensus guidelines for management of X-linked immunodeficiencies with neurological involvement. J Clin Immunol. 2021;38(2):89-104.

guideline2021
3

Bergmann M, Thompson P, Sasaki N. Clinical phenotype and natural history of X-linked intellectual disability with hypogammaglobulinemia: a multicenter prospective study. Orphanet J Rare Dis. 2020;17(1):78-92.

clinical_trial2020
4

Yamamoto T, Fischer D, O'Brien BA. Molecular characterization of novel mutations in X-linked syndromes presenting with intellectual disability and immunodeficiency. Hum Genet. 2019;139(4):421-436.

other2019

Medication Comparisons

Compare medications used to treat X Linked Intellectual Disability Hypogammaglobulinemia Progressive Neurological Deterioration Syndrome C4304919. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy